Guangbo Kang

1.1k total citations
36 papers, 802 citations indexed

About

Guangbo Kang is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Biotechnology. According to data from OpenAlex, Guangbo Kang has authored 36 papers receiving a total of 802 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 8 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Biotechnology. Recurrent topics in Guangbo Kang's work include Gut microbiota and health (13 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Probiotics and Fermented Foods (4 papers). Guangbo Kang is often cited by papers focused on Gut microbiota and health (13 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Probiotics and Fermented Foods (4 papers). Guangbo Kang collaborates with scholars based in China, Slovenia and Canada. Guangbo Kang's co-authors include He Huang, Mengxue Gao, Lina Wang, Xiaocang Cao, Jiewen Wang, Min Hu, Ario de Marco, Xiaoming Cheng, Xiaobo Li and Liang Bai and has published in prestigious journals such as Biochemical and Biophysical Research Communications, International Journal of Molecular Sciences and Small.

In The Last Decade

Guangbo Kang

33 papers receiving 795 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guangbo Kang China 18 466 156 115 96 84 36 802
Katia Pane Italy 19 664 1.4× 168 1.1× 42 0.4× 106 1.1× 32 0.4× 35 1.1k
Masayuki Ohara Japan 18 985 2.1× 89 0.6× 144 1.3× 233 2.4× 98 1.2× 34 1.4k
Kęstutis Sužiedėlis Lithuania 16 526 1.1× 62 0.4× 52 0.5× 107 1.1× 110 1.3× 48 920
Sang‐Chul Lee South Korea 17 384 0.8× 88 0.6× 61 0.5× 129 1.3× 51 0.6× 56 833
Yuwen Cong China 19 563 1.2× 73 0.5× 74 0.6× 72 0.8× 73 0.9× 56 1.1k
Yuping Huang China 19 539 1.2× 79 0.5× 46 0.4× 49 0.5× 116 1.4× 45 1.1k
Shriram G. Bhosle India 13 455 1.0× 155 1.0× 69 0.6× 26 0.3× 44 0.5× 21 719
Annelies Van Hecke Belgium 14 913 2.0× 141 0.9× 154 1.3× 38 0.4× 78 0.9× 28 1.4k
Francesco M. Mancuso Spain 19 789 1.7× 95 0.6× 72 0.6× 142 1.5× 142 1.7× 42 1.6k

Countries citing papers authored by Guangbo Kang

Since Specialization
Citations

This map shows the geographic impact of Guangbo Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangbo Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangbo Kang more than expected).

Fields of papers citing papers by Guangbo Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guangbo Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangbo Kang. The network helps show where Guangbo Kang may publish in the future.

Co-authorship network of co-authors of Guangbo Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Guangbo Kang. A scholar is included among the top collaborators of Guangbo Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guangbo Kang. Guangbo Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Jiahao, Kaihua Ji, Guangbo Kang, et al.. (2025). Butyrate-engineered yeast activates Nppa and Sgcg genes and reduces radiation-induced heart damage via the gut-heart axis. Pharmacological Research. 213. 107642–107642. 2 indexed citations
2.
Guo, Yufei, Mengxue Gao, Lina Wang, et al.. (2025). An Engineered Probiotic Consortium Based on Quorum‐Sensing for Colorectal Cancer Immunotherapy. Advanced Science. 12(46). e12744–e12744. 1 indexed citations
3.
Du, Xiaobing, Guangbo Kang, Jiang Xu, et al.. (2025). Bacterial Armory: Engineering Dual Photosensitized Bacteria for a Triple‐Modal Therapy on Tumors. Small. 22(5). e11296–e11296.
4.
Guo, Yufei, Mengxue Gao, Ling Jiang, et al.. (2025). Synthetic microbial consortia based on quorum-sensing for disease therapy. Bioresources and Bioprocessing. 12(1). 125–125.
5.
Kang, Guangbo, et al.. (2025). Flexible Regulation of Optical Properties Based on Structure Size‐Driven Intermolecular Interactions for Phototherapy. Advanced Science. 12(27). e2501468–e2501468. 2 indexed citations
6.
Chen, Wanyi, Yufei Guo, Mengxue Gao, et al.. (2025). Noncanonical amino acid-aided synthesis of anti-PD-L1 bispecific nanobody for colon cancer immunotherapy. Communications Biology. 8(1). 1844–1844.
7.
Kang, Guangbo, et al.. (2024). Intermolecular Interaction Between BODIPY and TPE Enhances Phototherapy. Advanced Optical Materials. 12(15). 4 indexed citations
8.
Wang, Jiewen, Guangbo Kang, Huiying Lu, et al.. (2024). Novel bispecific nanobody mitigates experimental intestinal inflammation in mice by targeting TNF‐α and IL‐23p19 bioactivities. Clinical and Translational Medicine. 14(3). e1636–e1636. 7 indexed citations
9.
Wu, Jiahao, He Huang, Lina Wang, et al.. (2024). A tailored series of engineered yeasts for the cell-dependent treatment of inflammatory bowel disease by rational butyrate supplementation. Gut Microbes. 16(1). 2316575–2316575. 22 indexed citations
10.
Kang, Guangbo, Jiewen Wang, Xingjie Gao, et al.. (2022). Breaking through the therapeutic ceiling of inflammatory bowel disease: Dual-targeted therapies. Biomedicine & Pharmacotherapy. 158. 114174–114174. 20 indexed citations
11.
Wang, Jiewen, et al.. (2022). Research Progress and Applications of Multivalent, Multispecific and Modified Nanobodies for Disease Treatment. Frontiers in Immunology. 12. 838082–838082. 55 indexed citations
12.
Wang, Jiewen, Ping Wang, Miao Zhang, et al.. (2022). Design of nanobody-based bispecific constructs by in silico affinity maturation and umbrella sampling simulations. Computational and Structural Biotechnology Journal. 21. 601–613. 14 indexed citations
13.
Wang, Lina, Xiaoming Cheng, Mengxue Gao, et al.. (2022). Positive Interventional Effect of Engineered Butyrate-Producing Bacteria on Metabolic Disorders and Intestinal Flora Disruption in Obese Mice. Microbiology Spectrum. 10(2). e0114721–e0114721. 36 indexed citations
14.
Hu, Yawei, Guangbo Kang, Lina Wang, et al.. (2021). Current Status of Mining, Modification, and Application of Cellulases in Bioactive Substance Extraction. Current Issues in Molecular Biology. 43(2). 687–703. 6 indexed citations
15.
Deng, Yong, Chengcheng Song, Guangbo Kang, et al.. (2020). Comparative genomics analysis of Acinetobacter haemolyticus isolates from sputum samples of respiratory patients. Genomics. 112(4). 2784–2793. 14 indexed citations
16.
Hu, Min, Guangbo Kang, Xin Cheng, et al.. (2020). In vitro affinity maturation to improve the efficacy of a hypoxia-inducible factor 1α single-domain intrabody. Biochemical and Biophysical Research Communications. 529(4). 936–942. 17 indexed citations
17.
Bai, Liang, Mengxue Gao, Xiaoming Cheng, et al.. (2020). Engineered butyrate-producing bacteria prevents high fat diet-induced obesity in mice. Microbial Cell Factories. 19(1). 94–94. 46 indexed citations
18.
Bao, Zeqing, et al.. (2018). Effects of reaction conditions on light-dependent silver nanoparticle biosynthesis mediated by cell extract of green alga Neochloris oleoabundans. Environmental Science and Pollution Research. 26(3). 2873–2881. 27 indexed citations
19.
Wang, Xueting, et al.. (2018). Biases in Prokaryotic Community Amplicon Sequencing Affected by DNA Extraction Methods in Both Saline and Non-saline Soil. Frontiers in Microbiology. 9. 1796–1796. 14 indexed citations
20.
Li, Ruowei, Guangbo Kang, Min Hu, & He Huang. (2018). Ribosome Display: A Potent Display Technology used for Selecting and Evolving Specific Binders with Desired Properties. Molecular Biotechnology. 61(1). 60–71. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katia Pane Breakdown of academic impact, for papers by Masayuki Ohara Breakdown of academic impact, for papers by Kęstutis Sužiedėlis Breakdown of academic impact, for papers by Sang‐Chul Lee Breakdown of academic impact, for papers by Yuwen Cong Breakdown of academic impact, for papers by Yuping Huang Breakdown of academic impact, for papers by Shriram G. Bhosle Breakdown of academic impact, for papers by Annelies Van Hecke Breakdown of academic impact, for papers by Francesco M. Mancuso
Rankless by CCL
2026